Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study

BACKGROUND: Rash eruptions are a common side-effect of pemetrexed, for which the administration of 8 mg/day of dexamethasone for 3 days from the day preceding pemetrexed administration is recommended. This study aimed to prospectively assess the effectiveness of prophylactic administration of low-do...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurada, Takumi, Nokihara, Hiroshi, Koga, Tadashi, Zamami, Yoshito, Goda, Mitsuhiro, Yagi, Kenta, Hamano, Hirofumi, Aizawa, Fuka, Ogino, Hirokazu, Sato, Seidai, Kirino, Yasushi, Goto, Hisatsugu, Nishioka, Yasuhiko, Ishizawa, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255977/
https://www.ncbi.nlm.nih.gov/pubmed/35325241
http://dx.doi.org/10.1093/oncolo/oyab077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255977/
https://www.ncbi.nlm.nih.gov/pubmed/35325241
http://dx.doi.org/10.1093/oncolo/oyab077

Ejemplares similares